Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VALEANT PHARMACEUTICALS INTL Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 218.78 M 339.02 M 335.75 M 235.07 M 461.51 M
    Net Receivables 144.51 M 173.55 M 229.68 M 187.99 M 171.86 M
    Total Inventories 72.97 M 80.15 M 130.75 M 136.03 M 112.25 M
    Progress Payments & Others -13.92 M -12.48 M -14.30 M -12.78 M -13.93 M
    Prepaid Expenses 6.45 M — — — —
    Other Current Assets 33.78 M 358.12 M 149.77 M 33.90 M 25.05 M
    Current Assets Total 470.04 M 950.83 M 845.94 M 599.44 M 770.67 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 0.00 0.00 0.00 0.00 0.00
    Property, Plant & Equipment Net 90.23 M 109.99 M 94.12 M 230.13 M 233.26 M
    Property, Plant & Equipment Gross 178.16 M 202.58 M 183.60 M 401.61 M 416.40 M
    Accumulated Depreciation 87.93 M 92.59 M 89.48 M 171.49 M 183.14 M
    Other Assets 612.23 M 374.55 M 544.41 M 659.11 M 517.95 M
    Deferred Charges 101,000.00 514,000.00 9.80 M — —
    Tangible Other Assets 29.70 M 32.52 M 44.36 M 43.30 M 65.17 M
    Intangible Other Assets 582.43 M 341.51 M 490.26 M 615.80 M 452.78 M
    Total Assets 1.17 B 1.44 B 1.48 B 1.49 B 1.52 B
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 666,000.00 1.66 M 9.24 M 495,000.00 929,000.00
    Accrued Payroll 23.38 M 17.75 M 37.09 M 47.21 M 36.24 M
    Income Taxes Payable 2.55 M 2.53 M 39.65 M 47.32 M 20.27 M
    Dividends Payable 0.00 0.00 6.51 M 6.43 M —
    Other Current Liabilities 223.96 M 152.06 M 109.61 M 93.63 M 79.54 M
    Current Liabilities Total 292.20 M 208.38 M 256.21 M 243.94 M 192.20 M
    Long Term Debt 447.86 M 782.55 M 778.20 M 788.44 M 793.14 M
    Provision for Risks & Charges 3.74 M 5.03 M 12.76 M 0.00 0.00
    Deferred Taxes -11.64 M -54.01 M -17.51 M -17.13 M 13.82 M
    Deferred Income 0.00 0.00 0.00 0.00 0.00
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 236.92 M 79.32 M 24.43 M 39.49 M 46.48 M
    Total Liabilities 969.08 M 1.02 B 1.05 B 1.05 B 1.05 B
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 203.42 M 414.10 M 430.39 M 433.94 M 476.22 M
    Common Stock 818,000.00 893,000.00 944,000.00 928,000.00 842,000.00
    Capital Surplus 1.07 B 1.19 B 1.26 B 1.22 B 1.00 B
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves -1.16 M -4.21 M 17.94 M -21.54 M 4.71 M
    Unappropriated (Free) Reserves — — — — —
    Retained Earnings -883.27 M -859.56 M -851.81 M -770.35 M -534.20 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 19.28 M 85.51 M 26.23 M — —
    Unrealized Gain (Loss) on Marketable Securities -1.08 M -8.36 M — — —
    Treasury Stock 0.00 0.00 0.00 0.00 —
    Total Liabilities & Shareholders Equity 1.17 B 1.44 B 1.48 B 1.49 B 1.52 B
    Common Shares Outstanding 81.75 M 89.29 M 94.42 M 92.76 M 84.22 M